A new algorithm designed to consider all forms of diabetes when diagnosing patients is among the additions in the American ...

A University of Virginia Center for Diabetes Technology-developed algorithm, paired with a continuous glucose monitor, can help users better manage their Type 2 diabetes by recommending insulin-dose ...

A University of Virginia Center for Diabetes Technology-developed algorithm—paired with a continuous glucose monitor—can help users better manage their type 2 diabetes by recommending insulin-dose ...

Tandem Diabetes Care has secured a new FDA clearance for its insulin dose-calculating algorithm, opening up its use to adults with Type 2 diabetes. The Control-IQ+ program—now with the added ...

The AACE released the 2026 update to its algorithm for the management of adults with type 2 diabetes. Clinical Advisor, a trusted source of medical news and feature content for healthcare providers, ...

Algorithm with glucose monitor improves insulin dosing and boosts time in safe blood sugar range in type 2 diabetes.

A University of Virginia Center for Diabetes Technology-developed algorithm – paired with a continuous glucose monitor – can help users better manage their type 2 diabetes by recommending insulin-dose ...

Generic dapagliflozin is indicated to lower heart failure hospitalization risk in type 2 diabetes with established ...

Dapagliflozin was first approved in 2014 and works by reducing the reabsorption of glucose and sodium in the kidneys. The ...

The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people with insulin-treated type 2 diabetes (T2D), a new randomized trial showed.